CC
ICPT

Corton Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Corton Capital’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,485
Closed -$142K – 401
2022
Q4 		$142K Buy
11,485
+228
+2% +$3.23K 0.12% 241
2022
Q3 		$157K Sell
11,257
-4,367
-28% -$70.3K 0.19% 204
2022
Q2 		$216K Sell
15,624
-7,992
-34% -$128K 0.2% 213
2022
Q1 		$384K Sell
23,616
-9,449
-29% -$148K 0.17% 169
2021
Q4 		$539K Buy
+33,065
New +$557K 0.24% 81

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Corton Capital's ICPT Position: Q1 2023 in Review

Corton Capital sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2023, closing a stake of 11,485 shares — an estimated $142K sold.

Corton Capital first reported a position in ICPT in Q4 2021 and held it in 5 quarters. The position peaked at $539K in Q4 2021. 144 funds tracked by Wall St. Rank hold ICPT as of Q1 2023.

  • Corton Capital reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Corton Capital sold 11,485 Intercept Pharmaceuticals, Inc. shares in Q1 2023, an estimated $142K.
  • Corton Capital first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2021 and held it in 5 quarters.
  • Corton Capital's Intercept Pharmaceuticals, Inc. position peaked at $539K in Q4 2021.
  • 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2023.

Based on Corton Capital's 13F filing for Q1 2023, filed 15 May 2023.